NBC SECURITIES, INC.

Broker-Dealer

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 791540 BIRMINGHAM, AL

Position in REGN

as of Mar 31, 2026 · filed Apr 14, 2026 Compact

Position Value

$336,871

-$15,873 QoQ

Shares Held

436

-4.6% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

NBC SECURITIES, INC. holds $4,320,734 across 55 Biotechnology names. REGN ranks #2 (7.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	HALO	Halozyme Therapeutics, Inc.	11,280	$729,026
2	REGN	Regeneron Pharmaceuticals, Inc. This page	436	$336,871
3	AXSM	Axsome Therapeutics, Inc.	1,793	$303,052
4	PTGX	Protagonist Therapeutics, Inc	2,547	$268,453
5	INBX	Inhibrx Biosciences, Inc.	3,800	$255,474
6	TSHA	Taysha Gene Therapies, Inc.	54,058	$241,639
7	BBIO	BridgeBio Pharma, Inc.	3,092	$229,611
8	MIRM	Mirum Pharmaceuticals, Inc.	2,420	$223,559

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$336,871	436	-4.6%	Shares	Sole	2026-04-14
2025-12-31	$352,744	457	-8.6%	Shares	Sole	2026-01-29
2025-09-30	$281,135	500	+449.5%	Shares	Sole	2025-11-14
2025-06-30	$47,775	91	-26.0%	Shares	Sole	2025-07-08
2025-03-31	$78,010	123	-23.1%	Shares	Sole	2025-04-09
2024-09-30	$168,198	160	-20.8%	Shares	Sole	2024-10-15
2024-06-30	$212,308	202	0.0%	Shares	Sole	2024-07-10
2024-03-31	$194,422	202	+0.5%	Shares	Sole	2024-04-05
2023-12-31	$176,536	201	0.0%	Shares	Sole	2024-02-07
2023-09-30	$165,414	201	—	Shares	Sole	2023-11-03
No filing history on record for this holder in this stock.